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INTRODUCTION 
Otomycosis is a superﬁcial, sub acute, or chronic infection of the 
outer ear canal, unilateral  mostly, that ischaracterized by 
inﬂammation, pruritus, and scaling. Otomycosis is a common 
condition encountered in ENT practice more in chronic or persistent 
ear infection .It is prevalent more in warm and humid  climates . 
In Indian subcontinent, otomycosis has been consistently present  in 
many cases presenting with discharging ears.  
Predisposing factors such as self-inflicted trauma (use of q-tips to 
clean itching in ear), failure in the defence mechanism in 
EAC(epithelial coating changes , changes in pH, quantitative and 
qualitative changes in ear wax), long term hearing aid /prosthesis, 
swimming with water trapped in EACbacterial infection, abuse of 
nonspecific broad spectrum antibiotics,  steroids, neoplasia and 
immunological disorders, all of which may render the host prone  to 
the development of otomycosis [2 ,5 ,6] .  
Following clinical exam (otoscopy) it is possible to confirm 
diagnosis via fungal examination. Aspergillus and Candida spp.are 
most commonly detected fungi in EAC infections, are opportunistic 
and usually of varied pathogenicity, being part of the normal 
microbiota from different body parts [7 ,8] . Treatment regimens vary 
 
 
from termination of infection and/or controlling predisposing 
factors, to local debridement (microaspiration) and/or the use of 
antimicrobial agents (topic/systemic) [9 ,10]    . 
Although otomycosis is a clinical entity throughout the world, there 
are only a few major studies regarding its true impact and frequency 
in Brazil [88 ,89 ,90] . 
The present paper is an attempt at assessing the frequency of 
predominant symptoms and patients suffering previously from 
CSOM by clinical and mycological diagnosis. 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
Apart from the use of topical  antibiotic drops, the moist conditions 
produced by the discharge alkaline pH , and epithelial debris are 
also responsible for the secondary fungal infections . Distribution is 
worldwide with greater incidence in humid , hot and dusty 
environments of subtropics and tropics [1 ,2] 
Overview of the literature reveals otitis media to be a common 
medical problem in India [3 ,4] . According to WHO, defines CSOM as 
otorrhoea through a perforated TM for atleast 2 wks .As it is 
accepted that Acute otitis media treated  incompletely usually 
precedes CSOM these variations in transition from acute to chronic 
imply that consensus has not been established clearly for the 
transition time . 
CSOM should also be understood as a different entity from chronic 
Otitis media with effusion.  Having no active infection or 
perforation as well as from a chronic TM perforation without 
presence of active middle ear disease. 
 Fungi can either be the primary pathogen or be superimposed on 
bacterial infections or can be secondary pathogen in previously 
perforated tympanic membrane.  Fungal otitis externa can be acute , 
subacute or chronic  caused by filamentous fungi or yeasts af fecting 
 
 
squamous epithelium  of external auditory canal .  It is mainly 
characterized by pruritus, ear ache, discharge, hearing loss, aural 
fullness, and rarely tinnitus. 
Multiple  factors which usually predispose to otomycosis i nclude  
immunocompromised host, trauma , ear picking, use of headgear, 
swimming, use of oils, instrumentation of ear and malnutrition in 
children [1 -7] lack of personal hygiene ,self-cleaning attempts by oil 
instillation accompanied by  indiscriminate use of topical ear drops 
predispose to  otomycosis. Aspergillus is a fungus of the 
Ascomycetes class that occurs worldwide and may occur as 
saprophyte , parasite or frank pathogen in man .It is found in  
moulds on fruits , grain and plants .  
Wide spectrum of fungal agents such as Aspergillus, Penicillium, 
Mucor, Rhizopus, Scopulariopsis, Absidia and Candida are 
involved, species of Aspergillus and Candida are found to be  the 
most common etiological agents  
 
 
  
 
 
HISTORICAL  PERSPECTIVE: 
CSOM first described by Hippocrates as early as  450 B.C., and it 
still persists to present itself even today as one of the most 
perplexing universally observed medical problems of childhood and 
a leading cause of hearing loss [15] . According to WHO survey, 42 
million people (older than 3 years) worldwide have hearing loss. 
The major cause for hearing impairment is otitis media which is 
second only to common cold as a cause of infection in childhood 
[16].  
It is estimated that about 90% of the people have atleast one 
episode of otitis media by their second birthday. For children less 
than fifteen years old, the most frequent diagnosis made in clin ical 
practice for ear discharge is otitis media [17] . 
Following are few headings to discuss pathogenesis of CSOM :  
A)  Eustachian tube function—3 important functions of clearance, 
ventilation and protection which can be impaired by 
endo/exogenous causes . When a persistent perforation of TM is 
present either due to a ventilation tube(grommet) or 
spontaneously , middle ear “gas cushion “ is affected. Resulting 
in negative ear pressures in middle ear , retrograde movement of 
nasopharyngeal secretions through ET. Young children are more 
 
 
prone to such abnormalities due to short, more horizontal floppy 
orientation of ET. Immunity against organisms by antibody 
production has been found to be more of local phenomenon than 
systemic response. The recovery from otitis media is related 
closely to mucosal immunity in tympanum.  Reduced ciliary 
motility in middle ear and ET mucosa has been implicated for 
the same. 
GERD also has propensity in theory to contribute to ET 
dysfunction. 
Usually a thin pinkish mucosa is associated with  a healthy 
epitympanic processes which becomes thick, edematous maybe 
with polyps , granulations or cholesteatoma filled middle ear .  
   Particular note to be made of is infection changes in mastoid 
and middle ear by exudate rich in fibrin.  The primary factor 
being inflammation to epithelium ,tissue proliferation in  growth 
of granulation tissue into gaps through inflamed epithelium into 
exudate while normal epithelium attempts to cover the raw 
areas. 
Connective tissue in massive columns form between promontory 
and ear drum or numerous epithelium lined cavities (cystic 
appearance) Adhesions follow as this collagenous scar tissue 
becomes organized .  
 
 
 Keratin and mucus producing cells, have been demonstrated 
adjacent to each other by Paparella , Bendak, Tos,Friedman). 
More of this is present in chronic and secretory otitis media. 
Appearance of cells producing more of mucus(glycoprotein)  or 
keratin is only reaction to minor influence of environment. 
Nevertheless, these reactions may prove to be the main 
manifestations of the pathological process .  
CSOM is a major reason for acquired hard of hearing in children 
.Most treatment approaches have been unsatisfactory or or 
difficult to cure it effectively; eg. Parenteral aminoglycosides  
are ototoxic potentially requiring long periods of followup and 
hospitalisation. 
With a global burden of more than 330 million people suffering 
from it at one point of time in their lives, with 60% having 
significant hearing loss .90% burden of disease is borne by 
developing countries in S.E. Asia , Africa and Western Pacific 
regions. 
Complications of CSOM: 
Chronic mastoiditis Middle ear , mastoid cavity erosion lead 
to Facial Nerve injury/paralysis, lateral sinus thrombophlebitis, 
meningitis, labyrinthitis, brain abscess.  
 
 
     Bottle feeding in infants , attending congested centres like 
day care centres , passive smoking are some of the risk factors 
for development of otitis media.  
Topical quinolones are more effective than other antibiotics 
(ofloxacin /ciprofloxacin) than IM gentamycin , neomycin-
polymyxin for otorrhoea. 
  Combined topical and systemic antibiotics are no better than 
topical antibiotics use alone.  
CSOM amenable to medical management is mainly to control 
infection , eliminate otorrhoea , and improvement of hear ing by 
eventual healing of perforation as long term goals.  
Gavarret and Andral in first described fungal infections in  external 
auditory canal in 1843,following which  Virchow suggested the 
term ‘otomycosis’. Wolf described the relationship of various fungi 
to this condition. Pacini in 1851 first  described preparation 
tomanage otomycosis . Cleansing and drying were postulated as 
essential to management to aid in symptomatic management but 
doubt of need for any  additional measures necessary remained 
controversial. In other studies, Lakshmipathi, Geaney and Murthy 
showed  that all cases observed wereaffected by  Aspergillus or 
Candida species [6,7]  . 
 
 
There is  abundance of  fungi in vegetable material , soil which 
following drying up in tropical climates and windblown as small  
fungal spores , which is evident with increase in infection rates  
with the onset of rains, (relative humidity may be upto >80%.) 
The prominent  role A. niger has in otomycosis was further 
exemplified in the 60’s and 70’s (Damato et al, 1964; Bezjak, 1970) 
,the formerstrained on cleansing and drying to be beneficial in 
reducing recurrence to huge extent with emphasis on  the role 
tolnaftate could have  in its management . 
 Stern et al suggested were also proponents for the idea of 
meticulous drying , cleansing.  Otomycosis originally has been 
suggested as a fungal infection of the EAC.Expansion of the terms 
meaning to include fungal infection upto middle ear and mastoid 
cavities was suggested by Paulose et al. ). 
 Haruna et al in 1994 added to histopathological observations in 
cases   
ANATOMY 
Development of external ear :  
The otic placode is the first hint of a future ear and is present 
during the third week of intrauter ine growth. The auricle forms 
 
 
frommesoderm of the 1 s t  and 2nd pharyngeal arches; its growth 
occurs via development of six hillocks of His around 5 thweek . The 
following six structures evolve from these hillocks:  
1. tragus, 2.  helix, 3. helical crus, 
4.antitragus, 5. antihelix  and 6. lobule. 
The external ear is composed of the auricle and external auditory 
canal having  subcutaneous tissue and elastic cartilage (mesoderm)  
, protected by skin and  adnexa. Arising from dorsal part of 1 s t 
branchial cleft between 1 s t   and 2nd branchial archesby 8 th wk 
primary External auditory meatus (future lateral 1/3 rd of EAC) is 
formed surrounding mesoderm forms the cartilage around. 
Endoderm of 1 s t pouch in contact with cleft allows mesoderm to 
grow between the layers with most medial cells of the ectodermal 
meatal plug forms outer layer of TM. 
 
 
 
 
 
 
 
3 hillocks in the 1st arch , and remaining (hillocks 4, 5, and 
6) from 2ndarch on both sides of the 1 s t cleft. Final fusion 
occurs by 12 th week . 
Fat is present in lobule but no cartilage . EAC is usually around 24 
mm long with 1-2 ml volume.Outer 1/3 rd canal is made of 
fibrocartilage, whereas the  medial 2/3 rd is bony. 
 
External auditory meatus 
 it is not possible with this view alone  to understand the 1st and 
2nd bends or the A-P orientation differences in canal. As it does not 
let us visualise the course above and below (as a result of upward 
prominence of bone just after the bony-cartilaginous junction .hence 
the constriction naturally formed called ‘isthmus’. Distinct 
 
 
angulations present incanal divide it  into 3 sections outer 1 s t and 
2nd cartilaginous and inner 3 rd bony part. 
the horizontal plane occur at the first and second  bends of the canal. 
The angulation at 1 s tis termed as “conchomeatal angle .An 
appropriate name for the angle formed at second bend is 
“cartilaginousbony angle (CB). Water and debris have easy chance 
of being trapped easily in lower  angle of Tympanic membrane 
referred to as sulcus. 
 
 
 
 
Concha extends to continue as cartilaginous part while the bony 
portion is developed from squamous and tympanic portions of the 
temporalbone. Hence ,the external auditory canal  which is initially 
a rather straight tube  early in life assumes “S” shaped orientation 
in adulthood  with length being  superiorly 2.5cm approx..  and 
inferiorly 3.0cm. 
SKIN  
Stratified squamous epithelium lines the EAC which continues with 
the pinna skin and the epithelial lining  of the TM. hair follicles, 
sebaceous and ceruminous glands are found in subcutaneous layer  
the cartilaginous canal < 1 mm in thickness. The bony canal lacks 
subcutaneous elements and is merely 0.2 mm thick. Coronal section 
of the ear canal shows magnified view of  skin of the cartilaginous 
canal. Ceruminous glands (Modified type of apocrine sweat) excrete 
cerumen which primarily has antibacterial properties , and has 
 
 
slightly acidic pH and protects from EAC maceration to jointly 
contribute to unsuitable environment  to fungi .But cerumen if 
excessively viscous may also obstruct, retain debris and water, 
infection may supervene. 
Keratin is known for absorbing moisture forming excellent medium 
for bacterial growth. With these defences hampered, external otitis 
may result giving scanty white thick discharge , maybe blood tinged 
with granulation tissue and /or fuffy to off -white otorrhoea with 
small white or black conidiophores on hyphae . In case of thick 
secretions, with crusting positive , H202or antibiotic topical drops 
will soften them .Unless TM can be fully observed, it is not 
advisable to flush out /syringe out ear contents avoiding potentially 
ossicular disruption /hearing loss, giddiness and tinnitus.  
In case of edematous /narrow canal wall, cotton wick can be 
carefully inserted for applying topical medications and facilitate 
drainage. 
 
 
 
.  
Pathogenicity of fungi is  attributed to minor intradermal 
abscesses or abrasions in EAC and TM with hemorrhagic 
granulations resulting in thrombosis of blood vessels  situated 
adjacent and hence prone to avascular necrosis and  finally 
perforation of tympanic membrane.  
Tympanic membrane :  
 TM is a translucent, smooth, pearly-white membrane with  avg.  
thickness of 0.074 mm .elliptical and approximately 10 mm high 
and 8 mm wide weighing approximately 14 mg .slanted at an angle 
of around 55 ̊  to floor ,  
 
 
The TM is slightly concave , being displaced inwardly by about 
2mm except at umbo where there is an outward protrusion due to 
inferior tip of manubrium of malleus.  
The  outer edge of TM is a fibrocartilaginous ring or annulus 
(annular ligament), embedded in a groove in tympanic bone called 
tympanic sulcus  which is deficient superiorly at notch of Rivinus. 
TM is thickest anterosuperiorly and inferiorly near the annulus (.09 
mm) and most thin in posterosuperior quadrant (.054 mm). 
considering its dimensions , it is a uniquely resilient structure due  
to its layered architecture .  
 
 
 
 
 
• 3 layers of pars tensa: outer epithelial  layer  from ectoderm 
of 1 s t visceral cleft , 
•  middle fibrous layer from mesoderm between 1 s t   visceral 
cleft and tubotympanic recess  & inner mucosal layer from a 
part of the recess  
• Fibrous layer disorganized in pars flaccida  
 
Outer cutaneous layer differentiable into external squamous 
and deeper cuboidal epithelium. Outward migration of outer 
epithelial layer begins at umbo continues outward through 
EAC (rate of this centrifugal  at eardrum around 0.05 mm /day 
). 
Middle fibrous layer maybe subdivided into outer Radial fibres ( 
giving the tent like shape of TM )and inner layer of circular 
(circumferential ) fibres giving it flexibility . .Middle ear cleft 
consists of middle ear cavity , mastoid air cells , Eustachian tube , 
aditu and mastoid antrum. It is an irregular space containing the 
ossicles malleus , incus and stapes . 
 
Middle ear :maybe divided into  
 
 
1. Epitympanum:lies above level of short process of malleus 
.Separated from hypotympanumand mesotympanum by mucosal 
membranes and folds.laterally bounded  by pars   flaccida 
superior to anterior and posterior malleolar folds ,lower part of 
wedge shaped attic wall called scutum . 
Medial : Bone superior to facial nerve(tympanic part)  
Contents : head of the malleus , body of the incus 
 
2. Mesotympanum:  Middle ear medial to pars tensa & tympanic 
annulus  
2  recesses extending backward difficult to visualize often are 
sinus tympani , facial recess – very common  locations for 
cholesteatoma .Contains long processes of malleus, incus,  
stapes, oval and round window, CN VII and partly stapedius 
and tensor tympani muscles.  
 
3. Hypotympanum:  Middle ear cavity below level of bony 
tympanic annulus  
4. . Anterior tympanum or Pro-tympanum:  Middle ear cavity in 
front of bony tympanic annulus 
5.Posterior tympanum:  Middle ear cavity behind bony tympanic 
annulus  
 
 
 
 
 
 
Malleus handle connects with TM loosely to short process via  
small cartilaginous insert on its  end .Stability is achieved at umbo 
where collagen fibres of TM converge .  
Malleus head and body of Incus articulate via saddle -shaped joint  
 
 
Incus lenticular apophysis connects with head of stapes in a 
shallowjoint (ball and socket cartilaginous type) , stapes footplate 
having  a fibrous attachment with the oval window rim with helpof 
annular ligament. A single layer of epithelium line all  ossicles 
middle ear cavity. 
Tensor tympani muscle from cartilaginous  bony wall of Eustachian 
tube turns almost 90  ̊  at  processus cohleariformis continue to 
upper part of manubrium.  Tensor tympani gets supplied by branch 
of Mandibular nerve (CN V).  
It contracts when  the sound stimulation is strong, sudden and 
threatening enough to produce a "startle reaction".  
Arising below from pyramid in posterior wall of middle ear,  
stapedius  muscle(smallest striated muscle in body )continues and 
inserts into neck of stapes. 
 
Contraction of stapedius muscle causes fixation of stapes helping to 
reduce transmission up to 30 dB for lower frequencies < 1-2 KHz.   
Functions of acoustic reflex: 
1. Protection of inner ear from damage due to excess noise.  
vascular, lymphatic and nerve supply to the ear .  
 
 
 
   Sensory innervation  : 
1) CN V (the auriculo temporal nerve for anteromedial and 
anterosuperior  pinna),  
2) greater auricular nerve (derived from C2,3) 
. supplies  postero lateral , postero medial, and inferior auricle  
3)  CN  X (Arnold’s nerve supplies the concha ),  
4)  CN VII (supplying sensory fibres to  EAC  in posterior and 
inferior pinna ),  
 
 
 
 
 
Blood supply : 
1) ECA(external carotid artery)     posterior auricular Artery.  
Superficial temporal A with  Occipital artery.  
2) Venous drainage by  the, external jugular, posterior auricular, 
superficial temporal, and retromandibular veins.  
Lymphatics  drain to the parotid LNs anteriorly to  cervical LNs. 
posteriorly 
 
EXTERNAL AUDITORY MEATUS  : The EAC consists of  
Outer 1/3RD  cartilaginous part. inner 2/3 rd  bony part connected 
with each other termed as bony -cartilaginous junction .  
 
 
 
MIDDLE EAR :  
Various names have been used to air filled anatomic middle  ear 
spaces anterior malleus (head). Proctor [80] , discussed development 
of these spaces (1964) mentioned about an anterior extension of the 
attic, (supratubal recess). Trillsch and Wigand (81) described it as 
sinu epitympani.  
 Terms like supratubal recess, anterior attic recess, recessus 
protympanicum and geniculate sinus have been used synonymously.  
Between 3 rd and 7 th fetal months, there is gradual absorption of the 
gelatinous tissue in middle ear cleft. Simultaneously, the primitive 
tympanic cavity forms in growth of endothelium lined from the 
Eustachian tube into the cleft.  
The middle ear spaces are hence developed from 4 sacs /pouches 
(saccus medius, anticus,  superior and posticus) as outgrowths from 
eustachian tube.  
Saccus mediusattic divide later into anterior , medial and 
posterior saccule.  
Saccus anticus/ anterior scaccule of sacccus medius anterior 
epitympanum. The slower developing saccus anticus meets the 
 
 
anterior saccule at level of the semicanal for tensor tympani, hence 
giving rise to horizontal tensor tympani fold.  
The space thus formed above the tensor fold and anterior to the 
tensor tendon is the anterior attic compartment.    
Below is a picture of microscopic view of recesses during 
development :  
Air cell like spaces :supratubal recess surrounded by petrosal cells 
_arrows) C : cochlea ,L :Lateral SCC F: Facial Nerve  
 
Clinical picture :  
Considerable difference exists in  clinical appearance of 
aspergillosis and candidiasis of the ear . Aspergillosis presents 
usuallyas moist inflammation changes in deep ear canal filled with 
large keratin  debris having wet tissue-paper appearance.  
Candida causes more maceration and edematous in  ear canal  
filling up lumen with curd like debris.  
 
 
Otomycosis may even lead to TM perforations AND invasion to 
middle ear. to maintain clinical scenarios documentation and 
standardization ,it becomes imperative for  otolaryngologist to 
define otomycosis as primary or secondary.  
1) Primary otomycosis  :- Otomycosis in EAC an 
immunocompetent person in presence of intact TM with no 
other external or middle ear pathology.  
A. Absence of  otitis externa. at  time of presentation (canal 
inflammation / stenosis of the EAC 
B. Presence of signs of otitis externa. (due to otomycosis and 
not vice versa. 
      2)Secondary otomycosis . When preexisssting otomycosis is 
present in the EAC alongwith existing history of otitis 
media/externa and/or h/o postoperative ears or  trauma,  with fungal 
infection in other parts 
.(a)Immunocompromised absent . No comorbidities like HIV, DM, 
or granulomatous diseases 
.(b)Immunocompromise is Present as detected by lab studies  
 
 
 
 
RELEVANT MYCOLOGY 
Colonies are usually in shades of green to white sometimes 
comprising a thin felt of conidiophores. Under microsope , 
chains of conidia(single celled maybe divergent or in columns 
, cylindrical , ellipsoid, globose ).Conidiophores are smooth – 
rough walled hyaline with phialides flask shaped , narrow 
pointed apical part ,a cylindrical basa l part and distinct neck. 
Aspergillus invades multiple organ systems of 
body.Naosorbital. Endocardial .Cutaneous . Central nervous 
system Pulmonary (Allergic bronchopulmonary aspergillosis  : 
fungal ball , invasive pulmonary aspergillosis)  
Asp. fumigatus colony resembles cottony , powdery or velvety 
whitish initially changing to dark greenish to gray /tan 
growing best at 45degree Celsius  uniseriate club shaped  
vesicles( 30-50μ diameter)  with phialides ,conidiophores long 
(300 micrometre) conidia on distal half arising in chains 
tending to sweep towards central axis .On microscopy , 
uniseriate phialides  
 
 
 
A typical colony of Aspergillus fumigatus  in our Microbiology lab.  
Apergillus flavus is commonly associated with aflatoxins.Rough, 
spiny conidiophores with brown to yellow to green velvet colonies,  
uni and biseriate phialides in all directions cover entire vesicle.  
 
 
 
 
Aspergillus flavus colonies in Test tube and culture plate 
respectively. 
Candida : 
Yeasts are unicellular budding organisms.(do not produce mycelia) 
usually forming visible colonies with 48 hours in culture plates 
.Moist , soft growth of these polymorphic variety of yeasts (hyphae, 
yeast cells , pseudohyphae .  
 
 
 
A culture tube showing Candida colonies grown in our 
lab(cream coloured smooth surfaced , waxy ) . 
 
Over 20 species of Candida(commonly Candida albicans, C. 
parapsilosis, C. glabrata, C. tropicalis)    are known to infect 
human living on skin ,mucous membranes.  Secreted Proteases 
aid in virulence of Candida spp in invasion of keratin 
protective layer to initiate EAC infection to further result in 
increased vascular permeability , congestion , raised 
temperature and decreased pH.Adherence of yeast to skin cells 
is supposedly facilitated by acid protease proportions . 
 
Dermatophytes: group of closely related fungi causing superficial 
infections 10-20% ( keratinophilic) .Main three genera 
Microsporum ,Trichophytonand Epidermophyton .It is not always 
possible by usual KOH mount microscopy(low specificity) and 
fungal culture(low sensitivity) to make confirmatory diagnosis in 
these infections .Zoophilic or anthrophilic in nature ,they are well 
suited to life on skin eliciting minimum inflammatory 
reaction.Polymerase chain reaction with usage of primers targeting 
dermatophyte specific sequences of chitin synthase 1 gene maybe 
considered gold standard . Hints at diagnosis  
 
 
  Epidermophyton : absence of  microconidia ; clubshaped 
macrconidia with  smooth thin walls.  
  Microsporum: multicelled macroconidia with  rough, thick 
walls. 
  Trichophyton: macroconidia mostly absent .If  present,  
pencil-shaped with smooth , thin walls. 1 -2 μ microconidia 
considered abundant 
 
In our case we had 10% cases of miscellaneous fungi 
including Derrmatophytes .The most appropriate treatment for 
the same is important as for example ; Griseofulvin is only 
effective in dermatophytic infections (no action to Candida 
spp. and other moulds .Terbinafine is fungistatic against 
Candida but fungicidal against Dermatophytes .  
 
PATHOGENESIS AND PREDISPOSING FACTORS  
Spread of otomycosis can be linked to  histology and functioning of 
EAC.  Stratified keratinized squamous epithelium along external 
side of TM lines this 2.4 cm long, 9 mm wide canal. Medial to 
isthmus at interior tympanic recess, remains of keratin and cerumen 
tends to accumulate and it’s difficult area to clean. Cerumen  is 
bacteriostatic and antifungal to some extent contains  lipids (50-
 
 
70%), proteins, lysozymes ,free amino acids ,immunogloblins  and 
PUFAs. These fatty acids in unbroken skin possibly inhibit growth 
of bacteria.Hydrophobic nature of cerumen makes canal wall 
surface impermeable avoiding damage to epitheliuma and 
maceration . 
Cerumen also protects against intrusion by insects . EAC harbours 
normally microorganisms like Staph.  epidermidis, Corynebacterium 
sp,  cocci (Staph. aureus, Streptococcus, Gram-negative bacilli 
(Pseudomonas aeruginosa, H. influenza, Moraxella etc) and as  
Aspergillus , Candida sp. This balance of commensal non 
pathogenicorganisms exists in healthy non immunodeficient people . 
Majorrisk factors which may cause saprophytic fungi to behave as 
pathogen : - 
  Increasing skin pH level in EAC (excessive bathing).  
Swimmingregularly without adequate ear protection can 
predispose to otomycosis. In addition, cerumen has been 
speculated to be supportive for fungal growth. Consensus on this 
theory is not generally achieved .  
 Environmental  (heat, humidity) – epithelial alterations  .   
- Systemic factors (corticosteroids, reduced immunity, morbidity 
of debilitating conditions, tumours.Overzealous use of  Ofloxacin 
 
 
otic drops  may even predispose to  otomycosis. (.Jackman et al 
(2005) 
.Presence of longstanding CSOM , bacterial otitis externa and 
manipulation in post op mastoid cavities are easy targets for 
fungal contamination providing disrupted skin as a good medium 
for growth of fungi.  
 Epithelial damage reduces apocrine and cerumen glands capacity 
to excrete the protective secretions which modifies EAC 
environment making it ideal for unusual microorganisms(reduced  
pH 3-4) . 
- Social habits and conditions in females wearing traditional head 
covers (veils)have been reported to influence chances of  
otomycosis. Humidity in ear canal increases to create ideal pH 
for fungal spread. 
- protective acid/lipid balance of the ear is lost.  
- Dermatomycosis is also a factor on otomycosis specially by 
autoinoculation  
Bacterial otitis externa and clinical otomycosis often have 
indistinguishable symptoms. However pruritus mostly frequent in 
fungal infections, associated with ear discomfort, otalgia, ear  
 
 
discharge, feeling of ear blocking sensation , hard of hearing and 
tinnitus  . 
Usually presenting symptomatically as  unilateral only  rarely B/Las 
has been documented . 
 
A flavus, niger  fumigatus, Penicillium, Absidia , Rhizopus and 
Scopulariopsis are the commonly encountered agents with Candida 
sp, especially C. albicans being  part of normal human flora with 
propensity to cause otomycosis. [5 ,9] 
 
Aspergillus has in past caused even invasive ( malignant) otitis 
externa with local extension beyond bone and cartilage,  proving 
severe ,potentially fatal. This is more commonly seen in 
immunodeficiency, diabetes& uncontrolled cases.  Aspergillus 
fumigatus is more responsible for such morbidity when compared to 
Aspergillus niger.  Aspergillus has rare chance of causing 
tympanomastoiditis in some  immunocompetent people also. 
Management of Aspergillus  sp. induced Invasive otitis externa 
classically is extensive surgical debridement , long-term antifungal 
therapy with Itraconazole/Amphotericin B. Despite such 
precautions, this condition can be associated with significant 
morbidity and mortality, due to late diagnosis,  comorbidities 
 
 
present already in patient [91] . Treatment failure due to the side 
effects of amphotericin B, may require suboptimal therapy and 
interruption/ decrease of antifungal agents.  Currently, voriconazole 
is considered for first  line therapy in such scenarios.(high intrinsic 
anti-Aspergillus action and well tolerated with good distribution in 
systemic than Amphotericin B).  
CSOM directly may impact hearing in patients CHL and SNHL).It 
also affects development of a child  (WHO,1998). Prime risk fac tors 
for CSOM being Upper respiratory tract infections ,necrotizing 
otitis media, otitis media with effusion and  poor living standards 
with lack of access to proper health care.  
 In case of accompanying concurrent TM perforation with severe 
otalgia, acute suppurative otitis media possibly by Aspergillus 
and/or other fungi has to be considered .  
Otoscopy may show mycelia, confirming the diagnosis. 
Erythematous EAC with  fungal debris with or without ear 
discharge greenish , black fuzzy OR white growth mixed with debris 
filling up the EAC and classical wet ‘blotting paper’ appearance 
with white mycelium maybe found . 
 Slight conductive deafness can be present due to mechanical block  
in the EAC . Local Hyperemia and minor bleed locally is expected 
in severe inflammation. 
 
 
Confirmation :  
Confirmation is to be done  by initial screening test for 
identification of  fungal elements in a KOH mount followed by  
fungal culture in case of confirmation. 
The characteristic examination resembles that of common moulds, 
with visible, delicate hyphae and spores (conidiophores) being seen 
in Aspergillus. 
 black headed filamentous growth (wet newspaper appearance) in 
Aspergillus niger, white colonies (cotton wool or wet blotting paper 
appearance soft caseous material with epithelia debris )  in Candida 
albicans, blue or green colonies in Aspergillus fumigatus & yellow 
colonies in Aspergillus flavus, 
Candida, a yeast, often forms mycelia mats with white character 
when it’s mixed with cerumen they appear yellowish. 
 Candidal infections can be more difficult to detect clinically 
because of its lack of characteristic appearance like Aspergillus an d 
not responding to aural antimicrobial. Otomycosis attributed to 
Candida is often identified by culture da ta. 
Hematoxylin and eosin staining is useful but not fully able to 
delineate fungal cell wall.  Silver staining is more sensitive for 
staining but colours cells too dark.  
 
 
More specific but less sensitive method is PAS (Periodic Acid 
Schiff) allows study of fungal morphology .When a mould is 
suspected in tissue material isolate ,Fontana Masson stain maybe 
used as a differential stain .  
 
Typical picture of  candida on endoscopy. 
 
Classical pic Aspergillus niger on otoendoscopic view 
 
 
 
Aspergillus flavus 
 Chronic otitis media   
Chronic or intermittent purulent otorrhoea  through a non-intact 
tympanic membrane persists for more than 6 weeks despite  
treatment  (non-intact includes a perforation or a ventilation tube) 
Otitis media is a multifactorial complex disease with 4  stages :  
1)Myringitis  
2 )Acute otitis media 
3)  Secretory otitis media and 
  4)chronic otitis media (persistent / intermittent  otorrhoea of 
minimum >6-12 wks duration  via perforated TM) (Brooke et al., 
2000) 
 
 
Lot of attention has been given to CSOM not only because of 
chronicity , morbidity and high incidence but also due to issues of 
microbial resistance and ototoxicity of OTC topical ear drops 
.(Haynes ,2002) 
CSOM associated with destructive osteitis, granulomations 
involving middle ear , mastoid ear bowl aremedically not curable 
and present with foul smelling purulent ear discharge non resolving 
with usual antibiotics.  Character of discharge size of TM  middle 
ear mucosa appearance on otoscopy should confirm diagnosis rather 
than history of hearing loss and last ear discharge . 
All draining ears are not necessarily linked to CSOM. Acute Otitis 
externa and media also present with discharge and otalgia. 
Discharge is much less foul smelling, profuse and tends to form 
mucus threads if tested on cotton gauze.  Also, incidence of  fever is 
higher in otitis media cases than otitis externa cases.  
CSOM however produces painless ear discharge mucoid in 
consistency without fever unless accompanied by intracranial 
infection. But even if ototscopy is not possible , any discharging ear 
>2- 3 months is likely CSOM, or carries higher risk of resulting in 
one since both AOM and otitis externa usually may be self limiting 
. 
 
 
Overall morbidity and prevalence in developing world ranges <10% 
of cases (Heyneman, 2000).Topical antibiotic ear drops for 
achieving a dry ear is the commonest conservative management 
used for CSOM without cholesteatoma (Loy et al.,2002). 
The IMCI guidelines require that children with stiff neck , fever , 
unable to drink, lethargic , h/o convulsions and emesis be swiftly 
referred to hospital and given antibiotics as these maybe danger 
signs for intracranial complications of CSOM.   
Cultures of ear discharge isolates are rarely sent for unless failed 
attempts in response to topical therapy.  One of the most widely 
prescribed drops is Neomycin/polymyxin B/hydrocortisone 
suspension. In a study in Nigeria , Gram negative  isolates had 75% 
sensitivity to Cefotaxime except for Pseudomonas aeruginosa 
(Resistance noted)   
Diagnosis of fungal infections :  
1. Microscopic examination of specimens for fungi is important 
in diagnosis when possible to obtain before culture . 10% 
KOH (potassium hydroxide ) is most commonly used medium  
.The slide is left to stand until clear, normally between five 
and fifteen minutes, in order to dissolve skin cells, hair, and 
debris. 
 
 
2. To enhance clearing dimethyl sulfoxide can be added to the 
slide. To make the fungi easier to see lactophenol cotton 
blue stain can be added. 
3. The slide is gently heated to speed up the action of the 
KOH.Adding calcofluor-white stain to the slide will cause the 
fungi to become fluorescent, making them easier to identify 
under a fluorescent microscope. 
Different fungal elements like hyphae , pseudohyphae , yeast 
cells . spores , sclerotic bodies maybe visualised in a KOH wet 
mount. 
 
Lactophenol cotton blue wet mount  : LPCB wet mount   
preparation is  widely and easily followed  method for fungal 
staining and observation .Lactic acid  preserves fungal elements 
while Phenol destroys any live organisms , and cotton blue stains 
chitin in cell walls of fungi.  
budding yeast cells  
Branching pseudohyphae 
seen under microscope in 
KOH mount. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LPCB mount  
Fruiting bodies of Aspergillus 
with phialides radiating in all 
directions with black 
pigmented conidia dispersed . 
Conidiophore 
Vesicle 
 
Metulae 
 
Conidia 
Vesicle bearing metuale and 
phalides which forms conidia 
 
 
 
 
 
 
 
 
 
Aspergillus on LPCB staining showing septate hyphae swollen 
vesicle giving rise to phialides from which clusters of conidiaa arise 
Advantages of Calcofluor over KOH mount  
1. Reduced  minimum time needed to  screen sample.  
2. KOH mount requires minimum  3-4 mins for each slide screening.  
3. Calcofluor mount can be easily seen for screening in less than 1  
    minute 
4. Reliable, better  sensi tivity as well as than KOH mount.  
5. Helps easy differentiation of background debris .  
 
 
 
 
Gram stain showing individual cells and psedohyphae in Candida . 
Culture :  
Sabouraud’s dextrose agar(SDA )  is routinely used for fungal 
culture. 
pH =5.6 does not allow bacterial growth . Chloramphenicol , 
cyclohexamide and were added as required avoid contamination by 
bacterial saprophytic fungi super infection. Cultures were subjected 
to incubation at :  25C and other at 37C  to help reveal  
dimorphism .Cultures underwent incubation for  2-3 weeks, 
examined for morphology of colonies  
(macroscopic)and  fungal morphology(microscopically) . 
 
 
 
 
Using a sterilized microneedle for sample handling for culture 
purpose.a drop of LPCB stain applied in clean microscopic slide 
.drop of 95%ethanol to cover slip after evaporation, the fungal 
isolate is spread out gently and on the slide over the stain. 
Examination under microscope after applying cover slip.  
 
 
 
AIMS OF STUDY 
Despite the fact that climatic condition in Tamil Nadu  may 
encourage fungal infection of middle ear, literature search reveals 
that not much work has been carried out on various aspects of 
fungal infection of middle ear. Keeping in view the high prevalence  
of fungal infection of middle ear in hot, humid and dusty areas, the 
study was carried out to  
 Objectively Isolate, characterize, and identify mycological 
agents in ear infection of CSOM patients.  
 Find out distribution of fungal aetiology in CSOM with and  
without an intact tympanic membrane.  
 
 
 
 
 
 
 
 
 
        MATERIALS AND METHODS  
100 patients attending ENT OPD and diagnosed to have CSOM  
were included in the study. Two aural swabs or whenever possible 
otomycotic debris were taken  up on sterile ear swab sticks . From 
one swab, wet mount preparation in 10% KOH (potassium 
hydroxide) solution and smear for Grams stain were prepared. to 
determine the presence or absence of fungal element (hyphae, 
spores and blastospores).  
The second swab / otomycotic debris was directly inoculated into 
SDA (Sabourad’s dextrose agar) medium.  
Secretion and pus were collected from 100 patients by two sterile 
cotton wool swabs taken out from External Auditory Canal or 
mastoid areas like cholesteatoma. One swab was used for direct 
microscopy and next for culture examination.. The presence of 
fungal structures is seen in potassium hydroxide (KOH) wet mounts.  
The microscopic examination shows discrete clumps of hyphae with 
conidiophores. In CSOM caused by A. niger, septate hyphae, 
sporulating vesicles and abundant black spores are seen. Collected 
swab was inoculated onto Sabouraud’s dextrose agar. The presence 
of fungal elements in stained smears was confirmed by growth of 
 
 
fungal colonies.Yeast like organisms like Candida may grow partly 
as chains of budding elongated cells joint at end (pseudomycelium 
and pseudohyphae).  
KOH MOUNT: KOH dissolves keratin and cellular material while 
not affecting fungi.Specimen is placed on a slide , a drop of 10 -20%  
KOH is added, covered with a coverslip , left for 20 min in 
incubator at 37 C to digest keratin , then examined microscopically 
.  
SDA  culture :qualitative method of testing for most fungi.  It is a 
general purpose peptone medium with dextrose (supporting growth 
of the fungi)and antibiotic like Chloramphenicol and cycloheximide 
prepared at a pH of 5.6 favouring growth of many species mainly 
dermatophytes. Agar should optimum moisture for inoculating 
specimen with sterile loop kept for observation in 25-30°C . 
Cultures are examined atleast weekly and should be observed till 
min. 4 weeks before reporting negative result.  
 
 
 
 
 
 
                RESULTS 
In this study , analysis of 100 patients with CSOM was done in ENT 
dept of PSG Institute of Medical Sciences &Research over a period 
of 2 years to determine incidence of  otomycosis in patients with 
CSOM . 
Clinical data was collected by means of a proforma and the 
observations made were analysed with a Master Chart as given in 
Annerxure. 
The results have been evaluated primarily keeping in mind the aims  
of the study using Microsoft Excel and SPSS softwares.  
In our study 70% of patients evaluated for CSOM were found to 
have coexisting otomycosis.  
 Frequency Percent 
<10 years 
5 5.0 
10-19  years 
19 19.0 
20-29  years 
20 20.0 
30-39  years 
18 18.0 
40-49  years 
17 17.0 
 
 
 
  
50-59  years 
11 11.0 
60-69  years 
2 2.0 
70-79  years 
4 4.0 
80-89  years 
3 3.0 
90-99  years 
1 1.0 
Total 
100 100.0 
 
 
 
 
 
 
 
 
 
 
 
Overall age distribution in our study 
From the table above it is evident that maximum incidence of 
otomycosis is in age group 20-29 yrs (20%) followed closely by 
19% ( 10-19 yrs age group) 18%(30-39 yrs )  with the least 
incidence being post 60 yrs of age.Overall incidence of CSOM 
Age-wise 
distribution 
CSOM with 
Otomycosis  
CSOM without 
Otomycosis 
p value 
< 40 years 39 (62.9%) 23 (37.1%) 0.24 
≥ 40 years  29 (76.3%) 9 (23.7%) 
 
 
coexisting with otomycosis is 39% before age of 40 years which is 
high when compared to 23% cases with CSOM only.  In age group 
more than 40 years, coexisting otomycosis and CSOM is present 
only in 7% cases while CSOM alone exists in 23%. 
 
In our study females have higher incidence of coexisting 
otomycosis with CSOM 41% compared to 27% in males .whereas 
incidence of CSOM alone is much higher in males (20%) compared 
to 12% in females.  P value is significant <0.05  
  
 
 
 
 
Clinical features of CSOM with Otomycosis  
Symptoms Pre operative incidence 
Ear Discharge 88 
Hearing Loss 64 
Itching 76 
Ear pain 72 
Ear block 61 
Most common complaint in our study at time of pr esentation was 
ear discharge (88%) followed by itching (76%)  and ear pain (72 %).  
The other complaints included hearing loss and ear block 64% and 
61% respectively.  
Gender CSOM with 
Otomycosis  
CSOM without 
Otomycosis 
p value 
Male 27 (57.4%) 20 (42.6%) 0.033* 
Female 41 (77.4%) 12 (22.6%) 
 
 
 
Overall distribution of symptoms in our study population  
Ear Discharge CSOM with 
Otomycosis  
CSOM 
without 
Otomycosis 
Total  p value 
Present 
(n=88) 
63 (71.6%) 25 (28.4%) 88  0.037* 
Absent (n=12) 5 (41.7%) 7 (58.3%) 12  
Total 68 32 100   
61
64
72
76
88
Ear block
Hearing Loss
Ear pain
Itching
Ear Discharge
Symptoms
no of cases
 
 
Odds ratio = 3.53 with 95% C.I =(1.02 – 12.16) 
 
The chance of a patient presenting with ear discharge having 
otomycosis as diagnosis is 3.5 times than not having otomycosis 
and is statistically significant. 
Hence ear discharge as  a significant symptom of otomycosis is  
statiscally significant( p value <.05) 
 
 
Hearing loss as a symptom for otomycosis is not as statiscally 
relevant when compared with CSOM cases alone (p value >0.05)  
 
 
Hearing Loss CSOM with 
Otomycosis  
CSOM without 
Otomycosis 
Total p value 
Present (n=64) 47 (73.4%) 17 (26.6%) 64 0.12 
Absent (n=36) 21 (58.3%) 15 (41.7%) 36 
Total 68 32 100  
 
 
Ear pain CSOM with 
Otomycosis  
CSOM without 
Otomycosis 
Total p value 
Present (n=72) 50 (69.4%) 22 (30.6%) 72 0.620 
Absent (n=28) 18 (64.3%) 10 (35.7%) 28 
Total 68 32 100  
 
Odds ratio =1.26 
The chance of a patient presenting with Ear pain having otomycosis 
as diagnosis is 1.3 times than not having otomycosis and is not 
statistically significant. 
 
 
 
Ear pain does not show as a major significant symptom for 
otomycosis with SOM cases when compared to CSOM cases alone 
in this study .  
(p value >0.05)  
 
Ear block CSOM with 
Otomycosis  
CSOM without 
Otomycosis 
Total  p value 
Present (n=61) 45 (73.8%) 16 (26.2%) 61 0.122 
Absent (n=39) 23 (59%) 16 (41%) 39 
Total 68 32 100  
 
 
 
Odds ratio =1.96  .The chance of a patient presenting with Ear 
block having otomycosis as diagnosis is 1.96 times than not having 
otomycosis and is not statistically significant. 
Itching CSOM with 
Otomycosis  
CSOM without 
Otomycosis 
Total p value 
Present (n=76) 55 (72.4%) 21 (27.6%) 76 0.096 
Absent (n=24) 13 (54.2%) 11 (45.8%) 24 
Total 68 32 100  
 
Odds ratio =2.22 
 
 
The chance of a patient presenting with Itching having otomycosis 
as diagnosis is 2.2 times than not having otomycosis and is not 
statistically so significant.  
Fungal culture shows :  
Fungus No.of Cases Percentage(%) 
Aspergillus sp 22 22 
Candida sp    15 15 
Other fungi including 
dermatophytes 
3 3 
Aspergillus sp + Candida sp    21 21 
Candida sp   + Other fungi 
including dermatophytes  
2 2 
Aspergillus sp + Other fungi 
including dermatophytes  
4 4 
Aspergillus sp + Candida sp   + 
Other fungi including 
dermatophytes 
1 1 
No culture 32 32 
Total 100 100 
 
 
 
Aspergillus as the most commonly identified fungus 22% .followed 
by aspergillus with Candida species .21% 
Candida as a fungus alone was foundin as high as 15% of cases. 
A mixed growth of Aspergillus with other species such as 
dermatophytes were also significant 4%. While other  combinations 
like Candida with dermatophytes (2%) and lastly Aspergillus , 
Candida and other fungal growth is  observed in 1% cases.Culture 
report failed to show fungal growth in 32% cases.
 
The number of fungal positive cases in our study was 68%. 
Aspergillus sp
Candida sp
Other fungi including…
Aspergillus sp + Candida sp
Candida sp   + Other fungi…
Aspergillus sp + Other fungi…
Aspergillus sp + Candida sp…
No culture
22
15
3
21
2
4
1
32
Culture positivity
No of cases
 
 
 
 
 
 
KOH smear/ microbiological finding 
Odds ratio = 5.23 with 95% C.I =(1.81 – 15.09) 
The chance of a patient having KOH smear positive to have  
otomycosis as diagnosis is 5.2 times than not having otomycosis 
and is statistically significant  
 
 
 
 
 
 
 
 
 
KOH smear CSOM with 
Otomycosis  
CSOM without 
Otomycosis 
p value 
Present (n=81) 61 (75.3%) 20 (24.7%) 0.001* 
Absent (n=19) 7 (36.8%) 12 (63.2%) 
 
 
 
DISCUSSION   
Review of  literature shows otitis media to be a common medical 
problem in India [18 ,19] .  Controversies in the past regarding 
existence of fungal cause of CSOM existed , now it has been proved 
clinically positive entity [8]  possibly because of manifold increase in 
incidence and the variety  of pathogenic fungi in  recent 
years. [9]  Morbidity is affected as  diabetes, , malignancy, , 
chemotherapy, HIV infection, irresponsible over the counter  
antibiotic use (topical or systemic) and steroid administration 
renders the individual prone to fungal infections of external as well 
as middle ear [10]   
Age:  
Relatively less number of available  studies regarding fungal 
CSOM.  In ourstudy, highest incidence was recorded in 2 nd , 3 rd and 
4 th decades of life 57% of the study population and this observation 
bears similarity to other studies  by various authors Mohanty JC et 
al[9], Chander J et al [10] Paulose KO [11] and Kaur R[12 .Only 
10% patients had otomycosis post age of 60 yrs while  only one 
patient in age group 90-99yrs had otomycosis . [15]   
 
 
The incidence decreased with increase in age post 45 -50 yrs of age. 
Higher incidence in young adults may be attribu ted to more 
exposure to airborne fungal spores in daily work and lifestyle  while 
extreme age groups are relatively spared.  
Gender : In present study, females 41(77.4%) had otomycosis 
compared to 27(57.4%) .In CSOM without otomycosis, males suffer 
more 20(42.6%) compard to females 12(22.6%).   In other studies , 
males predominantly suffer more than females  as far as fungal 
infection in  CSOM is concerned .Observation of various authors  
Laxmipati , Baskaran 55.80%, EO Nwankwo, AD salisu 57.5%, 
Rachna et al 55.55%, Gulati et al 67.50% shows more male affected 
with otomycosis.  
In contrast, the findings of present study correlate well w ith the 
observation of Reena Roy et al[11] who found females 57% were 
most commonly affected. In one “Mycological study of otomycosis”  
by Rajeshwari Raoet al. in Karnataka,among94 specimens of fungal 
isolates, males were41(43.6%) whereas 53 (56.4%) were females. 
Females are more affected than males in our case probably because 
they are more exposed to hot  , humid climates in household  , 
lifestyle  and habit of self probing with unsterile sticks , cotton 
 
 
buds , putting various oils(coconut oils) in EAC and less tendency 
to follow up in OPD for minor  itching and ear block symptoms . 
Reports of “sporostatic” action of coconut oil  may actually preserve 
the viability of fungal elements present in EAC, indirectly 
contributingto the problems.  
 
Most common Symptoms  
In our present study , ear discharge and itching (pruritis ) were 
primary complaints on 1 s t OPD visit (88%) and 76% respectively. 
Which correlate well with studies done in North Karnataka by 
Archana et al in a study on clino mycological profile of Otomycosis 
.Hearing loss and aural block  are less commonly found in present 
study which is similar to study by Archan S ,Channabasawaraj et 
al.,which shows aural block ,hearing loss and  tinnitus in lesser 
number .72% of otomycosis cases had itching while only 21% 
withonly CSOM complained of the same.  
 Most of our patients had unilateral disease as similar to other 
studies. 
Present report shows 3.5 times higher incidence of otorhoea  , 63% 
in otomycosis with CSOM than 17% in cases with  only CSOM as in 
 
 
other studies upto 90% being primary complaint [8 ,75]47%  had 
hearing loss as a primary complaint in our study which is 
comparable to study done in Hyderabad (Chapparbandi, Farha Naaz) 
as 35% had deafness. 
Present report has 45% ear block and deafness 47% comparable to 
studies published in Pakistan Journal of Medical Sciences by 
Khurshid Anwar etal. Which shows Ear block 30.8% , hard of 
hearing 50%. 
High incidence of A. niger  in external ear is common finding in 
most studies.Mostly aspergilli are not affected by wax 
(cerumen) [76] .First described by Cramer(in 1859),A. niger was 
isolated from human ear by him[7 7 ,78] , Aspergilluswas the primary 
cause of otomycosis [78 ,79] .Aspergillus in our study has accounted 
for 48% of all cases positive for fungus.(22% Aspergillus only ,  
21% with Candida spp, 5% with other species .  
Candida in our case series was detected in 41% cases  (15%only 
Candida , 
21% mixed with Aspergillus and only 3% with other saprophytic 
fungi) which is comparable to study In Brazil showing 51% . In one 
study in Tropical Medicine journal in Africa by Deepak Juyal et al.,  
 
 
Aspergillus species accounted for 47% of the cases, while 41% of 
the tests shows Candida species.  
This report aims to highlight the most common fungal etiology for 
otomycosis in our setting. Aspergillus spp(niger more than flavus 
and fumigatus) with all cases responding effectively to agents like 
clotrimazole , neomycin post proper aural toileting and following 
precautions to keep a dry ear .  otomycosis is a increasingly 
common  problem in Tamil Nadu ,Hyderabad Karnataka region .  
Prevalence of  increase in fungal infections  during and humid 
conditions has been   reported in multiple studies  [12] , [13] ,14]   
We suggest a definite search for fungi is desirable in all cas es of 
CSOM.  
The diagnosis based on microbiological findings should be prompt.  
The present study was undertaken to know the incidence of fungal 
infection in chronic suppurative otitis media, to know the pattern of 
fungal flora in chronic suppurative otiti s media.There is emerging 
need to follow up patients with more case studies of the same. In 
cases of CSOM, not responding to local antibiotics drops 
superimposed fungal infection must be suspected. There is a great 
disproportion of otomycosis coexisting with CSOM cases and the 
number of studies regarding clinical profile of the same .  
 
 
Otitis media is described as  inflammation of mucoperiosteal lining 
of middle ear, with or without intact tympanic membrane.It is one 
of most common childhood infections and a leading reason for 
antibiotic prescriptions in ENT . 
Otomycosis (fungal otitis externa ) amounts for significant number 
of  OPD cases as well .The disesase is highly prevalent in South 
Asian region.  [ 20]Chronic otitis media and CSOM are few of the 
common conditions encountered in a general otolaryngology clinic 
setting and its prevalence has been quoted to range from 9% 
to27.2% [2 ,  6]  among patients who present with signs and symptoms 
of otitis externa and up to 30%  [18 ,19]  in patients with discharging 
ears. Distribution worldwide with more prevalence in the  humid, 
and dusty areas of the tropics and [2 ,6 ,18 ,19] .Fungi can either be the 
primary pathogen or be superimposed on bacterial infections or can 
be secondary pathogen in previously perforated tympanic 
membrane. It is mainly characterized by pruritus, otalgia, aural 
fullness, hearing impairment and tinnitus. Various predisposing 
factors have been proposed for fungal ear infection, including 
immunocompromised host, steroid usage, trauma, swimming, ear 
picking, use of headwear, use of oils, instrumentation of ear, fungal 
infection elsewhere in the body like dermatomycosis and 
 
 
malnutrition in children [1 -7]  . Wide spectrum of fungal agents such 
as Aspergillus, Penicillium, Mucor, Rhizopus, Scopulariopsis, 
Absidia and Candida are involved, species of Aspergillus and 
Candida being the most common .Aspergillus and Candida  spp are 
the most commonly isolated fungi in India in most studies .  
Usual presentation of CSOM with otomycosis is similar to 
symptoms of  acute otitis externa in some cases .  The diagnosis of 
otitis externa relies on the patient's history, otoscopic examination 
under microscopic control, imaging studies .History of ear probing 
(accidental EAC injury ) , immune deficiency  status are not always 
present in many patients who initially complain mainly of minor ear 
itching. The widespread indiscriminate haphazard use of antibiotics 
and poor follow up among patients may result in persistence of 
coexisting low grade infection even after initial symptoms subside. 
. In general, Fungi causing otomycosis vary geographically from  
yeasts, moulds  to dermatophytes , Occasionally, other genera 
involved are  Absidia, Fusarium, Gymnoascus, Exophiala,Mucor,  
Scopulariopsis, [62-68]Aspergillus, in some publications has shown to 
be most frequently involved [69]  while others Candida is 
predominant [70] . Almost similar findings are recorded in Indian 
subcontinent [82-85].  
 
 
Few case series however do report incidence of Candida has been 
reported to be higher than Aspergillus [86 ,87] .High incidence of 
otomycosis in Indian subcontinent has been reported in past studies 
.Delay in proper diagnosis and severity of the disease prolong 
recovery .There is usually good recovery in immunocompetent 
patients on institution of topical antifungals. High clinical suspicion 
initially can prevent development of risk of recurrence  and reduce 
unnecessary usage of antibiotic and steroids for extended periods 
.Primary and secondary otomycosis clinical criteria can be 
standardized for better reporting of cases. 
Approx. 5-25% of otitis externa may progress to otomycosis. And 
10% of ases of external otitis are due to otomycosis.  
 
Management : 
Aspergillus  and Candida  spp are the most frequently isolated fungi 
in patients with otomycosis. Topical antifungals, such as 
clotrimazole, miconazole, bifonazole, ciclopiroxolamine, and 
tolnaftate, are potentially safe choices for the treatment of 
otomycosis, especially in patients with a perforated eardrum.  
 
 
 The oral triazole drugs, itraconazole, voriconazole, and 
posaconazole are effective against Candida  and Aspergillus , with 
good penetration of bone and the central nervous system.  
Recommendation in refractory  otomycosis due  to its mostly lack of 
ototoxicity  antifungal preparation Bifonazole was in common use  
during 80s [24 ,25] . . bifonazole 1% solution has similar  potency in  
comparison to  miconazole or clotrimazole . It has retarded fungal 
growth in most cases with efficacy of up to 100% [29 ,30] . 
Boric acid maybe used to treat fungal and yeast infections caused 
by Candida sp. Tolnaftate  1% solution can also be easily instilled 
into the ear [26] 
5-Fluorocytocine (flucytosine) penetrates fungal cells ,fluorouracil 
is formed as active drug, which competes with uracil and hence  
fungal RNA formation [27 ,28] . In our setting, all patients were given 
topical Clotrimazole , Neomycin with steroid combination and 
followed up weekly for atleast 4 wks or when patient did not turn 
up for review whichever was later.In follow up re -examination was 
done for alleviation of symptoms and most of them showed positive 
response. 
 
 
Bassiouny et al. had reviewed the efficacy of topical antifungal 
agents to conclude that Clotrimazole and econazole were mostly 
effective  
Systemic antifungal therapy: 
In patients who  fail response to topical therapy have invasive 
external otitis , systemic antifungal measures maybe used. 
Itraconazole may be tried in superficial external  otitis  but in case 
of  invasion, which includes TM perforation  voriconazole maybe 
useful. If perforation of TM does not heal easily , patients may need 
Tympanoplasty  (Wang et al, 2005). 
Resistance to Itraconazole has been seen in otomycotic  isolates of 
Aspergillus fumigatus and Aspergillus niger (Kaya et al, 2007, 
Snelders et al, 2008).  
One study shows topical ketoconazole effecting better resolution of 
symptoms with lower recurrence, whereas another study shows 
voriconazole to be more potent than itraconazole in vitro against 
Aspergillus  spp. Candida albicans  . 
Other authors suggested that in all cases of CSOM , mere 
instillation of topical ear drops (antibiotic/steroid)  is not 
mandatory .It may lead to bacterial flora suppression and flaring of 
 
 
normal commensal flora of EAC causing superinfection .Otologists 
need to develop a sense of suspicion in refractory ear discharge 
cases not responding to conventional treatment .At the very onset , 
aural toileting is justifiable to reduce the prevalence of  fungi in 
endemic regions. 
 
Complications :  
 Otomycosis is frequently seen more in patients with 
immunocompromise with more chances of complication and 
recurrence. They also require longer duration of  treatment and 
complications. 
Infrequent but reported complications include  
1. ear drum perforation ,  
2. Hearing loss (not fully reversible)  
3. Invasive temporal bone infection 
4. Meningoencephalitis 
5. Fungal otomastoiditis 
 
Malignant otitis externa has potential to rarely present as aggressive 
angioinvasive temporal bone infection.(otomastoiditis in case of  
invasive Aspergillus spp. More commonly nowadays found in 
 
 
patients of immunodeficiency. In these situations , recommended  
treatment is surgical debridement with systemic antifungal 
(Amphotericin B) for 3-4 wks 
Tympanic membrane involvement is likely a consequence of fungal 
inoculation in the most medial aspect of the external canal or direct 
extension of the disease from adjacent skin  
Otologist should remain alert for otomycosis and should c onsider 
obtaining hematological investigations and fungal cultures when 
this disease is suspected in immunocompromised host.  
 
 
 
 
 
 
 
 
 
 
LIMITATIONS OF STUDY 
1. Large number of patients eligible for study were lost to 
follow up and a few participants had to be excluded as swabs 
for culture could not be taken at time of initial presentation 
due to treatment previously with topical ear drops and lack of 
visible discharge in ear .  
2. There was no separate culture media used for transportation 
of swabs to microbiology lab . 
3. Most of the cases were chronic, so long term changes in 
predominant fungal flora could not be taken into account in 
all cases. 
4. It was not possible to get confirmatory culture results in a 
few 
due to inability to clean sample from ear discharge (eg in 
cases contaminated in excess with wax).  
 
 
 
 
 
 
  CONCLUSION  
A. Incidence of otomycosis superimposed on CSOM in our 
study is 68% of all cases tested .  
B. Incidence was higher in middle age and young adults than 
both extremes of age groups. 
C. Ear discharge , itching in EAC ,ear pain  were the most 
significant complaints in all cases  
D. Aspergillus is the primary fungi species effecting 
otomycosis in our study closely followed by Aspergillus 
spp with Candida, and subsequently major cause being 
Candida. 
E. KOH mount is effective as a primary means of screening for 
fungi  giving in present context sensitivity of 89.7% . but 
specificity for true negative cases was low 37.5% 
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ANNEXURE 
ABBREVIATIONS 
CSOM –CHRONIC SUPPURATIVE OTITIS MEDIA 
SDA-SABOURAUD’S DEXTROSE AGAR  
TM-TYMPANIC MEMBRANE 
KOH-POTASSIUM HYDROXIDE 
ET –Eustachian Tube 
GERD- Gastroesophageal reflux disease.  
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1 2 M 1 2 1 1 2 1 1 2 2 2 2 2 
2 6 M 1 1 2 1 2 1 1 1 1 1 2 1 
3 5 F 1 2 1 1 2 1 1 1 1 2 2 1 
4 6 F 1 2 1 2 1 1 1 1 1 2 2 1 
5 4 M 1 2 1 1 2 1 1 2 2 2 2 2 
6 6 F 1 2 1 1 2 1 2 1 1 2 2 1 
7 2 M 1 2 2 1 1 1 2 2 2 2 2 2 
8 3 F 1 1 1 1 1 1 2 1 1 1 1 1 
9 2 F 1 2 1 1 2 1 1 1 1 2 2 1 
10 3 F 1 1 1 1 2 1 2 2 2 2 2 2 
11 2 F 1 2 1 1 2 1 2 1 1 2 2 1 
12 5 F 1 1 1 1 1 1 2 1 1 1 2 1 
13 8 M 1 1 1 2 1 1 2 1 2 1 2 1 
14 5 F 1 2 1 2 1 1 2 2 2 2 2 2 
15 1 M 2 1 1 1 1 1 1 1 2 1 2 1 
16 2 M 1 1 1 1 2 1 2 2 2 2 2 2 
17 2 M 1 2 1 2 2 1 2 1 2 2 2 2 
18 5 M 1 2 2 1 1 1 1 1 2 2 1 1 
 
 
19 2 F 1 1 1 1 1 1 1 1 1 1 2 1 
20 2 F 1 1 2 2 1 1 1 1 1 2 2 1 
21 6 M 1 2 1 2 1 2 2 1 2 2 2 2 
22 2 F 1 2 1 1 1 1 1 1 1 2 1 1 
23 4 M 1 2 1 1 2 1 2 2 2 2 2 2 
24 10 M 1 2 2 1 2 1 2 1 2 2 2 2 
25 3 F 1 1 2 1 2 1 2 2 2 2 2 2 
26 4 M 1 2 2 1 2 1 2 2 2 2 2 2 
27 3 M 1 1 1 1 1 1 1 1 1 2 2 1 
28 8 F 1 2 1 1 2 1 1 1 1 1 2 1 
29 6 F 1 1 2 1 1 1 1 1 2 1 1 1 
30 4 F 1 2 1 1 1 1 2 1 1 2 2 1 
31 4 M 2 2 1 1 2 1 2 1 1 2 2 1 
32 3 F 1 1 2 1 1 1 2 2 2 2 2 2 
33 3 F 1 2 1 1 1 1 1 1 2 1 2 1 
34 6 M 2 1 2 2 1 1 2 2 2 2 2 2 
35 4 F 1 1 1 1 1 1 1 1 1 2 2 1 
36 9 F 1 2 1 1 2 1 1 1 1 1 2 1 
37 5 M 1 2 1 1 1 1 1 2 2 2 2 2 
38 4 F 1 2 1 2 1 1 1 1 1 1 2 1 
39 3 M 1 1 1 2 1 1 1 1 2 1 2 1 
 
 
40 3 M 2 1 1 1 1 1 1 1 2 2 2 2 
41 7 F 1 1 1 2 1 1 1 1 2 1 2 1 
42 1 M 1 1 1 1 2 1 1 1 1 2 1 1 
43 6 M 2 1 1 1 2 1 1 1 1 2 1 1 
44 6 M 1 2 1 1 1 1 1 1 2 2 2 2 
45 3 M 1 2 1 1 2 1 1 1 2 2 2 2 
46 6 F 1 1 1 1 2 1 1 1 2 1 2 1 
47 2 F 1 1 1 1 1 1 1 1 1 1 2 1 
48 9 F 1 1 1 1 1 1 1 1 1 1 2 1 
49 4 M 2 1 1 2 2 1 1 2 2 2 2 2 
50 3 F 1 1 1 1 1 1 1 1 1 1 2 1 
51 1 F 1 1 1 1 2 1 1 1 1 1 2 1 
52 2 F 1 1 1 1 1 1 1 2 2 2 2 2 
53 2 M 1 1 1 1 1 1 1 1 2 1 2 1 
54 4 M 1 1 1 2 1 1 1 1 1 1 2 1 
55 5 M 1 2 1 1 1 1 1 1 1 1 2 1 
56 5 M 1 1 1 1 1 1 1 1 1 2 2 1 
57 5 M 1 2 1 1 1 1 1 1 1 2 2 1 
58 4 M 1 1 1 1 1 1 1 1 1 2 2 1 
59 9 F 1 1 1 2 1 1 1 1 1 1 2 1 
60 3 F 1 1 1 1 1 1 1 2 1 2 2 1 
 
 
61 3 M 1 1 1 2 1 1 1 2 2 2 2 2 
62 4 F 1 1 2 1 2 1 1 1 1 2 2 1 
63 3 M 1 1 1 1 2 1 1 1 2 1 2 1 
64 2 F 1 1 1 1 2 1 1 2 2 2 2 2 
65 5 F 2 1 1 2 2 1 1 2 2 2 2 2 
66 8 F 1 1 2 2 2 1 1 1 2 2 1 1 
67 5 F 1 2 1 2 2 1 1 1 1 2 2 1 
68 5 F 1 2 1 2 2 1 1 1 2 2 2 2 
69 3 F 1 2 2 1 1 1 1 1 2 1 2 1 
70 2 F 1 1 1 1 1 1 1 1 1 2 2 1 
71 8 F 1 1 1 2 1 1 1 1 2 1 2 1 
72 6 F 1 1 2 2 1 1 1 1 1 2 2 1 
73 2 F 1 1 2 1 1 1 1 1 2 2 2 2 
74 4 F 1 2 1 2 2 1 1 1 1 1 2 1 
75 4 F 1 1 1 2 1 1 1 1 1 1 2 1 
76 7 F 1 1 1 2 1 1 1 1 1 2 2 1 
77 3 M 1 1 1 1 1 1 1 1 1 2 2 1 
78 5 M 2 1 1 1 1 1 1 2 2 2 2 2 
79 3 M 2 2 1 2 1 1 1 2 2 2 2 2 
80 2 M 1 1 2 1 1 1 1 1 2 1 2 1 
81 5 F 2 1 1 1 2 1 1 1 2 1 2 1 
 
 
82 6 F 1 1 1 1 1 1 1 1 1 2 2 1 
83 5 M 1 1 1 1 1 1 1 1 2 2 1 1 
84 4 M 1 1 2 2 2 1 1 1 2 2 2 2 
85 2 M 1 1 1 2 2 1 1 1 2 1 2 1 
86 2 F 1 1 2 1 1 1 1 1 1 1 2 1 
87 1 F 1 1 1 2 2 1 1 1 1 1 2 1 
88 4 M 1 1 2 1 1 1 1 2 2 2 2 2 
89 5 M 1 1 1 1 1 1 1 1 2 2 1 1 
90 3 F 2 1 1 1 2 1 1 1 2 2 2 2 
91 2 M 2 1 2 1 1 1 1 1 1 1 2 1 
92 3 F 1 1 1 1 1 1 1 1 1 2 2 1 
93 4 F 1 1 1 1 1 1 1 1 1 1 2 1 
94 5 M 1 2 1 1 1 1 1 1 2 1 2 1 
95 5 M 1 1 1 2 2 1 1 1 1 1 2 1 
96 1 M 1 2 2 1 2 1 1 1 1 2 2 1 
97 3 F 1 2 2 1 2 1 1 1 2 1 2 1 
98 4 F 1 2 2 1 1 1 1 2 2 2 2 2 
99 4 M 1 1 1 1 1 1 1 1 2 1 2 1 
10
0 
3 F 1 1 2 1 1 1 1 2 2 2 2 2 
 
 
 
CONSENT FORM 
 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS  
I Dr. Arijit Das,  am carrying out a study on the topic: INCIDENCE 
AND TYPES OF OTOMYCOSIS IN CHRONIC SUPPURATIVE 
OTITIS MEDIA IN PSGIMS& R.as part of my / our research project 
being carried out under the aegis of the Department of ENT  
(Applicable to students only): My / our research guide is:                         
Dr. S. Palaninathan. 
Sample size: 100.  
Location:_PSGIMS & R.  
We request you to kindly cooperate with us in this study. We 
propose collect background information and other relevant details 
related to this study. We will be carrying out:  
Initial interview (specify approximate duration):___20_______ 
minutes.  
Clinical examination (Specify details and purpose): Using otoscope 
or endoscope  to diagnose and take samples if required to 
effectively treat otomycosis and CSOM 
 
 
All data and patient details in this study collected in this study will 
be kept highly confidential.  
Benefits from this study: Identification of and typing of otomycosis 
causing fungi in patients and general population of Coimbatore  
leading to better treatment  
Risks involved by participating in this study: nil  
How the results will be used: Reference for understanding pattern 
of OTOMYCOSIS , its prime causes and following treatment to be 
given  
If you are uncomfortable in answering any of our questions during 
the course of the interview / biological sample collection, you have 
the right to withdraw from the interview / study at anytime. You 
have the freedom to withdraw from the study at any point of time. 
Kindly be assured that your refusal to participate or withdrawal at 
any stage, if you so decide, will not result in any form of 
compromise or discrimination in the services offered nor would it 
attract any penalty. You will continue to have access to the regular 
services offered to a patient. You will NOT be paid any 
remuneration for the time you spend with us for this interview / 
study. The information provided by you will be kept in strict 
confidence. Under no circumstances shall we reveal the identity of 
 
 
the respondent or their families to anyone. The information that we 
collect shall be used for approved research purposes only. You will 
be informed about any significant new findings - including adverse 
events, if any, – whether directly related to you or to other 
participants of this study, developed during the course of this 
research which may relate to your willingness to continue 
participation. 
Consent: The above information regarding the study, has been read 
by me/ read to me, and has been explained to me by the 
investigator/s. Having understood the same, I hereby give my 
consent to them to interview me. I am affixing my signature / left 
thumb impression to indicate my consent and willingness to 
participate in this study (i.e., willingly abide by the project 
requirements).  
 
Signature / Left thumb impression of the Study Volunteer / Legal 
Representative: 
 
Signature of the Interviewer with date:      
 Witness:  
 
 
PROFORMA 
 
Name:       Hospital no. 
Age/Sex:        IP no. 
Address:       Date: 
Clinical data 
Symptoms: 
Ear discharge: 
 onset , duration, progressive 
 Appearance, colour 
 Precipitating factors if any 
(swimming, probing) 
 Blood stained or not 
 Operated in past(+/-) 
Ear pain: 
 Intermittent , Progressive (+/-) 
 Associated with cold , headache , nasal symptoms  
 History of self probing in ear , itching (+/-) 
 Referrred pain 
 
 
Hearing loss : 
 Onset , duration 
 Severity , associated nasal complaints  
 Tinnitus, giddiness 
Nasal symptoms: 
 Allergy, recurrent nose block 
Throat: 
         Duration, onset and progression  
Others:  Weight loss , fever, vomiting.  
Past history:  
   Diabetes, Hypertensive, TB ,Asthma , previous surgery, drug 
intake etc 
Personal history 
Ocuupation, smoker / alcoholic , socioeconomic status,  
Sleep, apptite, bowel bladder habits  
Family history 
History of similar illness in family members  
 
 
 
General Examination: 
Built: Anemia ,cyanosis, clubbing , edema, lymphadenopathy  
Vital signs: Pulse, Temperature, blood pressure, Respiratory rate  
ENT examination: 
Ears: 
 Pinna, Pre and post auricular areas  
 Mastoid/tragal tenderness 
 EAC 
 TM appearance(when seen) 
 Tuning for tests 
Facial Nerve function 
Nose: 
External  framework, 
Anterior rhinoscopy 
Posterior rhinoscopy 
Examination of Paranasal sinus tenderness  
  
 
 
Throat: 
Oral cavity –Abnormality if any of lips , buccal mucosa, hard , soft 
palate, tonsils. 
Oropharynx: congestion, fullness.  
Indirect laryngoscopy:  
Systemic exam:CNS, CVS, Rspiratory system, Abdominal 
examination 
Routine: CBC, RBS,URINE ROUTINE 
       Chest X-RAY, Urea/Creatinine (>40 yrs)    
              OTOENDOSCOPY 
        EAR SWAB FOR KOH MOUNT , FUNGAL CULTURE 
              X.RAY Temporal bone( lateral oblique view)  (If planned    
for surgery) 
Treatment: Medical and/or Surgical  
Follow up: Improvement in symptoms 
  
 
 
  
 
 
 
